(Q40752751)

English

8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway

scientific article published on 4 February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway (English)

1 reference

Europe PubMed Central

23 September 2017

author name string

Yin Tintut

1

1 reference

Europe PubMed Central

23 September 2017

Farhad Parhami

2

1 reference

Europe PubMed Central

23 September 2017

Anastasia Tsingotjidou

3

1 reference

Europe PubMed Central

23 September 2017

Sotirios Tetradis

4

1 reference

Europe PubMed Central

23 September 2017

Mary Territo

5

1 reference

Europe PubMed Central

23 September 2017

Linda L Demer

6

1 reference

Europe PubMed Central

23 September 2017

language of work or name

0 references

publication date

4 February 2002

1 reference

Europe PubMed Central

23 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

23 September 2017

277

1 reference

Europe PubMed Central

23 September 2017

16

1 reference

Europe PubMed Central

23 September 2017

14221-14226

1 reference

Europe PubMed Central

23 September 2017

Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Glibenclamide relaxes vascular smooth muscle constriction produced by prostaglandin F2 alpha.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

The isoprostanes: unique bioactive products of lipid peroxidation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

EP(4) receptors mediate prostaglandin E(2)-stimulated glycosaminoglycan synthesis in human cervical fibroblasts in culture

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Prostaglandin E(2) increases cyclic AMP and inhibits endothelin-1 production/secretion by guinea-pig tracheal epithelial cells through EP(4) receptors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Localization of distinct F2-isoprostanes in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Increased formation of distinct F2 isoprostanes in hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Oxidized phospholipids and isoprostanes in atherosclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Role of lipids in osteoporosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Atherogenic high-fat diet reduces bone mineralization in mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Interleukin 4, interferon-gamma, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Identifiers

10.1074/JBC.M111551200

1 reference

Europe PubMed Central

23 September 2017

1 reference

Europe PubMed Central

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40752751&oldid=1906692988"